Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by thediggeron Nov 22, 2018 7:04am

97 Views

Post# 29008601

RE:RE:Hey WeedBuzz

really? Are you shorting this stock? If it is the case, be careful. Look what happened last week. Financials are coming and sales will be higher. Nobody expect profit at this stage. So the sales alone will move the price up a bit. If it goes down by Friday, it will be because of pure end of day manipulation, max0.075. If it is the case, I suggest you to cover before the weekend. Financials could be next week and it could be accompanied by the store locators. So, be really careful. But if you want my advice, this stock will be above the current price by Friday eod. Just by curiosity, what kind of decisions do you thing the management should have taken? Because they are actually doing great.

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December